Cristina F. Contreras

Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B‐acute lymphoblastic leukemia

S. Tasian, Elliot Stieglitz, Astrid Behnert, 2020, Pediatric blood & cancer.

Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP Consortium

Annette S. Kim, Traci M. Blonquist, Jeffrey A. Magee, 2018, Blood.

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

S. Hannenhalli, R. Kaplan, J. Drake, 2021, Cell.

Abstract CT142: GD2.Ox40.CD28.z CAR T cell trial in neuroblastoma and osteosarcoma

A. Gentles, H. Maecker, B. Sahaf, 2022, Cancer Research.

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.

S. Harmon, B. Turkbey, H. Maecker, 2023, Cancer cell.